Northern Trust Company of Connecticut’s Tandem Diabetes Care TNDM Stock Holding History

Northern Trust Company of Connecticut’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$24K	Buy	+95	New	+$21.7K	﹤0.01%	1980

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MACM

March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Company of Connecticut's TNDM Position: Q4 2013 in Review

Northern Trust Company of Connecticut opened a new position in Tandem Diabetes Care (TNDM) in Q4 2013: 95 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #1980 among its holdings.

61 funds tracked by Wall St. Rank hold TNDM as of Q4 2013.

Northern Trust Company of Connecticut held 95 shares of Tandem Diabetes Care worth $24K as of Q4 2013.
Tandem Diabetes Care was a new Northern Trust Company of Connecticut position in Q4 2013.
Tandem Diabetes Care made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1980 holding.
61 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.